Rhabdoid Tumor: A Comprehensive Guide

Overview

A rhabdoid tumor is a rare, aggressive cancer that primarily affects infants and young children, though it can occur at any age. These tumors are characterized by their rapid growth and tendency to spread (metastasize) to other parts of the body, such as the brain, kidneys, or soft tissues. Rhabdoid tumors are named for their resemblance to rhabdomyosarcoma (a type of muscle cancer) under a microscope, though they are distinct in their genetic and biological behavior.

Who It Affects

Rhabdoid tumors most commonly occur in children under the age of 2, with the majority of cases diagnosed before age 5. However, they can also affect older children and adults, though this is less common. The tumor can develop in various locations, including:

• Central Nervous System (CNS): Known as atypical teratoid/rhabdoid tumor (AT/RT), these account for about 1-2% of pediatric brain tumors.
• Kidneys: Called rhabdoid tumor of the kidney (RTK), these are rare but highly aggressive.
• Soft Tissues: Known as extra-renal rhabdoid tumors (ERRT), these can occur in muscles, skin, or other soft tissues.

Prevalence

Rhabdoid tumors are extremely rare, with an estimated incidence of fewer than 1 case per 1 million children annually. AT/RTs account for approximately 10-20% of CNS tumors in infants under 6 months. Due to their rarity, research and treatment options are limited, making them a challenging diagnosis for families and healthcare providers.

Symptoms

The symptoms of a rhabdoid tumor depend on its location in the body. Below are common symptoms associated with each type:

Atypical Teratoid/Rhabdoid Tumor (AT/RT - Brain)

• Headaches: Often worse in the morning or at night.
• Nausea and vomiting: Especially in the morning or without an apparent cause.
• Seizures: May be the first sign in some children.
• Balance or coordination problems: Difficulty walking, clumsiness, or frequent falls.
• Behavioral changes: Irritability, lethargy, or personality shifts.
• Increased head size: In infants, a bulging fontanelle (soft spot) or rapid head growth.
• Vision or hearing problems: Sudden changes in vision or hearing.

Rhabdoid Tumor of the Kidney (RTK)

• Abdominal swelling or mass: A noticeable lump or distension in the abdomen.
• Blood in the urine (hematuria): Urine may appear pink, red, or brown.
• Pain: Discomfort in the abdomen or side.
• High blood pressure: Due to the tumor affecting kidney function.
• Fever or weight loss: General symptoms of illness.

Extra-Renal Rhabdoid Tumor (ERRT - Soft Tissues)

• Lump or swelling: A painless or painful mass in the soft tissue (e.g., neck, limbs, or trunk).
• Pain: Depending on the location and size of the tumor.
• Limited mobility: If the tumor affects muscles or joints.
• Fever or fatigue: General symptoms of illness.

If you notice any of these symptoms in your child, especially if they persist or worsen, consult a healthcare provider promptly. Early diagnosis is critical for improving outcomes.

Causes and Risk Factors

Causes

The exact cause of rhabdoid tumors is not fully understood, but research has identified genetic mutations that play a key role. Most rhabdoid tumors are associated with mutations in the SMARCB1 gene (also known as INI1), which is a tumor suppressor gene. This gene helps regulate cell growth and division, and when mutated, it can lead to uncontrolled cell proliferation.

In rare cases, rhabdoid tumors may be linked to a genetic condition called rhabdoid tumor predisposition syndrome (RTPS), where individuals inherit a mutated SMARCB1 gene from a parent. However, most cases occur spontaneously without a family history.

Risk Factors

While the exact risk factors for rhabdoid tumors are not well-defined, the following may increase the likelihood of developing one:

• Age: Children under 2 years old are at the highest risk.
• Genetic mutations: Inherited or spontaneous mutations in the SMARCB1 gene.
• Family history: Rare cases of familial rhabdoid tumor predisposition syndrome (RTPS).
• Gender: Some studies suggest a slight male predominance, though this is not well-established.

It’s important to note that rhabdoid tumors can occur without any known risk factors, and having a risk factor does not guarantee the development of a tumor.

Diagnosis

Diagnosing a rhabdoid tumor requires a combination of imaging, laboratory tests, and biopsies. Due to the rarity of these tumors, diagnosis often involves a multidisciplinary team of specialists, including oncologists, radiologists, and pathologists.

Diagnostic Tests

• Imaging Tests:
  • MRI (Magnetic Resonance Imaging): The preferred imaging method for brain and spinal cord tumors (AT/RT).
  • CT Scan (Computed Tomography): Often used for kidney or soft tissue tumors to assess size and location.
  • Ultrasound: May be used for initial evaluation of abdominal masses.
  • PET Scan: Sometimes used to check for metastasis (spread) to other parts of the body.
• Biopsy: A small sample of the tumor is removed and examined under a microscope. This is the only way to confirm a rhabdoid tumor diagnosis. Pathologists look for characteristic cellular features and test for the loss of the SMARCB1 gene (INI1 protein).
• Lumbar Puncture (Spinal Tap): For AT/RTs, this test checks for cancer cells in the cerebrospinal fluid (CSF), which can indicate spread within the CNS.
• Blood and Urine Tests: These may be used to assess overall health, kidney function, and signs of metastasis.
• Genetic Testing: Testing for mutations in the SMARCB1 gene can confirm the diagnosis and identify familial predisposition.

Staging

Once diagnosed, the tumor is staged to determine the extent of the disease. Staging helps guide treatment decisions. For rhabdoid tumors, staging may include:

• Localized: The tumor is confined to its original site.
• Metastatic: The tumor has spread to other parts of the body, such as the lungs, liver, or bones.

Treatment Options

Treatment for rhabdoid tumors is challenging due to their aggressive nature and tendency to spread. A combination of therapies is typically used, and treatment plans are tailored to the child’s age, tumor location, and stage. Treatment often involves a team of specialists, including pediatric oncologists, surgeons, and radiation oncologists.

Surgery

Surgery is usually the first step in treatment, aiming to remove as much of the tumor as possible. The goal is to achieve a "gross total resection," meaning no visible tumor remains. However, due to the tumor's location (e.g., brainstem or critical organs), complete removal may not always be possible.

Chemotherapy

Chemotherapy uses powerful drugs to kill cancer cells or stop their growth. It is often used before or after surgery to shrink the tumor or eliminate remaining cancer cells. Common chemotherapy drugs for rhabdoid tumors include:

• Vincristine
• Cyclophosphamide
• Cisplatin or Carboplatin
• Etoposide
• Doxorubicin

High-dose chemotherapy followed by a stem cell transplant may be considered for some patients, though this approach is still under investigation.

Radiation Therapy

Radiation therapy uses high-energy rays to target and destroy cancer cells. It is often used for AT/RTs and may be delayed or avoided in very young children due to potential long-term side effects on brain development. Techniques such as proton therapy, which targets the tumor more precisely, may be used to minimize damage to healthy tissue.

Targeted Therapy and Immunotherapy

Emerging treatments, such as targeted therapy and immunotherapy, are being studied in clinical trials. These therapies aim to attack specific genetic mutations or boost the immune system’s ability to fight cancer. For example:

• Targeted Therapy: Drugs like tazemetostat (a EZH2 inhibitor) are being tested for rhabdoid tumors with SMARCB1 mutations.
• Immunotherapy: Treatments like checkpoint inhibitors or CAR-T cell therapy may be explored in clinical trials.

Clinical Trials

Due to the rarity of rhabdoid tumors, participation in clinical trials is often encouraged. Clinical trials offer access to cutting-edge treatments and contribute to research that may improve outcomes for future patients. Organizations like the National Cancer Institute (NCI) and St. Jude Children’s Research Hospital often conduct trials for rare pediatric cancers.

Living with Rhabdoid Tumor

A diagnosis of a rhabdoid tumor can be overwhelming for families. Managing the physical, emotional, and practical challenges requires a strong support system and access to resources. Below are some tips for daily management:

Medical Care

• Follow-Up Appointments: Regular visits with the oncologist to monitor for recurrence or side effects of treatment.
• Rehabilitation: Physical, occupational, or speech therapy may be needed to address treatment-related challenges (e.g., mobility issues, speech delays).
• Pain Management: Work with a palliative care team to manage pain and improve quality of life.

Emotional and Psychological Support

• Counseling: Mental health support for the child and family to cope with stress, anxiety, or depression.
• Support Groups: Connecting with other families affected by rhabdoid tumors through organizations like the CureSearch for Children’s Cancer or Alex’s Lemonade Stand Foundation.
• Child Life Specialists: Professionals who help children understand and cope with their medical experiences.

Nutrition and Hydration

• Balanced Diet: A nutritious diet helps support the immune system and recovery. A dietitian can provide personalized recommendations.
• Hydration: Adequate fluid intake is essential, especially if the child is experiencing vomiting or diarrhea from treatment.
• Supplements: Vitamins or supplements may be recommended if the child has nutritional deficiencies.

School and Social Life

• Educational Support: Work with the child’s school to create a plan for continued learning, including accommodations for missed school days.
• Social Activities: Encourage safe, age-appropriate activities to maintain social connections and a sense of normalcy.
• Siblings: Provide support and attention to siblings, who may also be affected by the family’s situation.

Prevention

There is no known way to prevent rhabdoid tumors, as most cases occur due to spontaneous genetic mutations. However, the following steps may help reduce risk or aid in early detection:

Genetic Counseling

Families with a history of rhabdoid tumors or SMARCB1 mutations should consider genetic counseling. A genetic counselor can assess the risk of passing the mutation to future children and discuss options such as:

• Pre-implantation genetic diagnosis (PGD) for families undergoing IVF.
• Prenatal testing for high-risk pregnancies.

Regular Check-Ups

For children with a known genetic predisposition, regular medical check-ups and imaging (e.g., ultrasounds or MRIs) may help detect tumors early. However, the effectiveness of surveillance is still being studied.

Awareness of Symptoms

Parents and caregivers should be aware of the symptoms of rhabdoid tumors, especially in infants and young children. Early detection can lead to earlier intervention and potentially better outcomes.

Complications

If left untreated or if treatment is unsuccessful, rhabdoid tumors can lead to severe complications, including:

• Metastasis: The tumor can spread to other organs, such as the lungs, liver, or bones, making treatment more difficult.
• Neurological Damage: AT/RTs can cause permanent damage to the brain or spinal cord, leading to disabilities in movement, speech, or cognition.
• Organ Failure: Tumors in the kidneys or other organs can impair their function, leading to life-threatening complications.
• Treatment Side Effects: Chemotherapy and radiation can cause long-term side effects, such as secondary cancers, heart or lung problems, or developmental delays.
• Death: Unfortunately, rhabdoid tumors have a high mortality rate, especially when diagnosed at an advanced stage. The 5-year survival rate for AT/RT is approximately 30-40%, while RTK and ERRT have similarly poor prognoses without effective treatment.

When to Seek Emergency Care

Resources and Support

For more information and support, consider reaching out to the following organizations:

• National Cancer Institute (NCI)
• CureSearch for Children’s Cancer
• St. Jude Children’s Research Hospital
• Alex’s Lemonade Stand Foundation
• Children’s Oncology Group (COG)

References

This article was informed by reputable sources, including:

• Mayo Clinic. (2021). Rhabdoid Tumor. www.mayoclinic.org
• National Cancer Institute. (2020). Atypical Teratoid/Rhabdoid Tumor (AT/RT) Treatment. www.cancer.gov
• St. Jude Children’s Research Hospital. (2022). Rhabdoid Tumors. www.stjude.org
• American Society of Clinical Oncology (ASCO). (2021). Rhabdoid Tumor: Symptoms and Signs. www.cancer.net
• Johannes E. A. Wolff, et al. (2018). Rhabdoid Tumors: Current Challenges and Future Perspectives. Journal of Clinical Medicine.